Circulation, Vol 54, 266-275, Copyright © 1976 by American Heart Association
WF Walsh, PV Harper, L Resnekov and H Fill
The short half-life positron emitter 13N, as labeled ammonia (13NH4+), was
evaluated as a myocardial imaging agent. Regional myocardial uptake of
13NH4 correlated with the distribution of labeled microspheres in
experimental myocardial infarction. Using intravenous 13NH4+, myocardial
scintigraphy was performed in 85 cardiac patients and 27 normal subjects.
Ninety-five scintigrams were suitable for analysis. Eighteen of 24 normal
subjects had homogeneous myocardial images; six had inhomogeneous images
attributable to early technical problems. Perfusion defects were observed
in the scintigrams of 82% (57/65) of patients with coronary artery disease,
being most common in patients with myocardial infarction (27/28). Six
sequential studies showed changes in perfusion consistent with the clinical
course of each patient. Scintigraphic abnormalities were also observed in
4/6 patients with valvular heart disease. 13NH4+ myocardial scintigraphy is
a valid and sensitive method of assessing regional myocardial perfusion and
is especially useful for sequential imaging at short intervals.
ARTICLES
Noninvasive evaluation of regional myocardial perfusion in 112 patients using a mobile scintillation camera and intravenous nitrogen-13 labeled ammonia
|
Circulation Home | Subscriptions | Archives | Feedback | Authors | Help | AHA Journals Home | Search Copyright © 1976 American Heart Association, Inc. All rights reserved. Unauthorized use prohibited. |